To return to the home page, click here
Contents of the Monthlies - Dec 94 to Jul 96
Arranged by Month, First Author, and a shortened Title
*Dec 94*
1. Keen RR et al: IL-1-beta induces differential
gene expression in aortic SMC's
2. Newman KM, et al: Cytokines activating
proteolysis are increased in AAA
3. Newman KM, et al: Cellular localization of MMP's
in AAA
*Jan 95*
1. Reilly JM, et al: Plasminogen activators in AAA
2. Wolf YG, et al: CAT findings associated with
rapid expansion of AAA's
*Feb 95*
1. Gadowski GR, et al: Beta-adrenergic blockade and
AAA expansion
2. Dobrin P, et al: Failure of elastin and/or
collagen as critical events in AAA
*Mar 95*
1. LaMorte WW, et al: Racial differences in AAA
2. Lalak N, et al: AAA rupture after coincidental
operation
*Apr 95*
1. Parodi JC. Endovascular repair of AAA....
2. Verloes A, et al: Genetic aspects of AAA in 313
pedigrees
*May 95*
1. Holmes DR, et al: Medial neovascularization in
AAA...
2. Moursi MM, et al: Inhibition of AAA in MoBlo by
beta-adrenergic blockade
*Jun 95*
1. Johansson G, et al: Incidence and mortality of
thoracic AA
2. Lederle FA, et al: Variability in measurement of
AAA
*Jul 95*
1. Evans JM, et al: AAA and dissections in patients
with temporal arteritis
2. Thompson RW, et al: The 92-kDa gelatinase in AAA
3. Schneiderman J, et al: Expression of fibrinolytic
genes in AAA.
*Aug 95*
1. Szekanecz Z, et al: AAA's produce IL-6 and
interferon-gamma
2. Ramsbottom D, et al: Linkage to chromosome 16 in
Ireland
3. Adembri C, et al: Ischemia/reperfusion of human
skeletal muscle
*Sep 95*
1. Tilson MD: An autoantigen in AAA and bovine MAGP-
36
2. Satta et al: Turnover of COL III in AAA
3. Cenacchi G, et al: Morphology of elastin in AAA
*Oct 95*
1. McMillan WD, et al: Localization of 72-dDa
gelatinase in AAA..
2. Wolf YG, et al: Screening for AAA during lower
extremity evaluations in vascular lab...
*Nov 95*
1. Shireman PK, et al: Increased plasminogen
activators in AAA
2. Halloran BG, et al: Macrophage products inhibit
SMC proliferation....
3. Kosierkiewicz TA, et al: Expression of MHC Class
II antigens by SMC's in AAA arterial media
*Dec 95*
1. Hall KA, et al: Abdominal wall hernia in patients
with AAA
*Jan 96*
1. Gregory AK, et al: Features of autoimmunity in
AAA
2. Hardman DTA, et al: Whose ruptured AAA should be
fixed?
*Feb 96*
1. Xia S, et al: Partial sequence of aortic
aneurysm-associated antigenic protein - 40 kDa.....
(AAAP-40)
2. Tilson MD, et al: Genetic susceptibility to AAA
resides in MHC Class II DR...
*Mar 96*
1. White GH, et al: Endoluminal versus open repair
of AAA
2. Brown PM, et al: Selective management of AAA in
a prospective management program
3. Kazmers A, et al: AAA repair in VA medical
centers
4. Petrinec D, et al: Doxycycline inhibition of AAA
in animal model
5. Ricci MA, et al: Anti-CD18 monoclonal antibody
slows AAA expansion in animal model Papers of the
*Apr 96*
1. Moore WS, Rutherford RB, for the EVT Investigators.
Transfemoral endovascular repair of AAA: Results of the
North American EVT phase 1 trial. J Vasc Surg 1996; 23:
543-53.
2. Sara J, Laara E, Juvonen T. Intraluminal thrombus
predicts repture of an AAA. J Vasc Surg 1996; 23: 737-
9.
*May 96*
1. Inflammatory abdominal aortic aneurysms: A case-
control study. Nitecki SS, Hallett JW Jr, Stanson AW, et
al. J Vasc Surg 1996; 23:860-9.
2. Results of endoluminal grafting in an experimental
aortic aneurysm model. Eton D, Warner D, Owens C, et al.
J Vasc Surg 1996; 23:819-31.
*Jun 96* - Highlights from SVS/ISCVS Mtg, Chicago
1. [Poster #3] May J, White GH, Yu W, Waugh RC, Stephen
MS, Harris JP. Concurrent comparison of endoluminal
repair vs no treatment for small AAA's. (from the
Harrisburg Polyclinic Medical Center, PA).
2. [Poster #4] Harris EJ, Dalman RL, Moon WK. Aortic
aneurysmorrhaphy in high risk patients: establishing
concurrent results for comparison with endoluminal
therapies. (Stanford Univ)
3. [Poster #41] Paik DC, Ramey WG, Capella JF, Yin X,
Tilson MD. Neovascularization in the AAA - eNOS, NO, and
elastolysis. (Columbia Univ, NYC).
4. [Poster # 48]. Shireman PK, McCarthy WJ, Pearce WH,
Shively VP, Cipollone M, Yao JST. Elevations of t-PA and
differential expression of u-PA in diseased aorta.
(Northwestern Univ Medical School, Chicago).
5. [Forum #9] Rasmussen TE, Hallet JW Jr, Mathieu-
Metzger RL, Richardson DM, Goronzy JJ, Weynand CM.
Genetic risk factors in inflammatory AAA's (I-AAA's):
Polymorphic residue 70 in the HLA-DRB1 gene as a key
genetic element. (Mayo Clinic, Rochester, Minnesota)
6. [Forum #10]. Hirose H, Ozsvath KJ, Xia S, Tilson MD.
Molecular cloning and expression of the cDNA for a
putative AAA-antigenic protein (AAAP). Columbia Univ in
the city of New York.
*Jul 96*
1. Sakalihasan N, Delvenne P, Nusgens BV, Limet R,
Lapiere CM. Activated forms of MMP-2 and MMP-9 in AAA's.
JVS 1996; 24: 127-33.
2. Patel MI, Melrose J, Ghosh P, Appleberg M. Increased
synthesis of matrix metalloproteinases by aortic smooth
muscle cells is implicated in the etiopathogenesis of
AAA. J Vasc Surg 1996; 24:82-92.
3. Hunter GC, Smyth SH, Aguirre ML, Baxter BT, Bull DA,
King DD, Wang YP, Hall KA, Putnam CW. Incidence and
histological characteristics of blebs in patients with
AAA's. J Vasc Surg 1996; 24: 93-101.
4. Schwartz LB, Belkin M, Donaldson MC, Mannick JA,
Whittemore AD. Improvement in results of repair of type
IV thoracoabdominal aortic aneurysms. JVS 1996; 24: 74-
81.
*August 96*
Ozsvath K, Xia S, Hirose H, Tilson MD. Two hypothetical
proteins of human aortic adventitia, with Ig kappa, collagenous,
and aromatic-rich motifs. Biochem Biophys Res Communications
1996; 225: 500-504.
*September 96*
1. Cook TA, Galland RB. A prospective study to define
the optimum rescreening interval for small AAA.
Cardiovascular Surgery 1996; 4: 441-448.
2. Balm R. Transfemoral endovascular aneurysm management
(thesis). Privately printed with support from the
Netherlands Heart Foundation and Endovascular
Technologies Inc (Menlo Park, USA). ISBN 90-393-1285-0
(1996)
*October 96*
Cole et al. Selective screening for AAA...
Chen et al. Predictors of death in ruptured and non-ruptured AAA..
Wills et al. Elastase-induced matrix degradation in arterial organ
culture...
*November 96*
Tilson MD and Boyd CD. The AAA: Genetics, Pathophysiology, and
Molecular Biology. Contents of volume 800, Proceedings of the
New York Academy of Sciences, 1996.
*December 96*
Tilson et al. 3 D structure and molecular evoluation of Mat-CAM-2.
*January 97*
1. Blum U, et al. Endoluminal stent-grafts for
infrarenal abdominal aortic aneurysms. NEJM 1997;
336:13-20.
2. Yusuf et al. Early results of endovascular aortic
aneurysm surgery with aortouniiliac graft, contralateral
iliac occlusion, and femorofemoral bypass. J Vasc Surg
1997; 25: 165-172.
3. Matsumura JS, Pearce WH, McCarthy WJ, and Yao JST for
the EVT Investigators. Reduction in aortic aneurysm
size: Early results after endovascular graft placement.
J Vasc Surg 1997; 25: 113-23
*March 97*
1. Moon et al. Simultaneous abd & thoracic stent graft placement.
2. Hallett et al. Long term durability of AAA repair
*Apr 97*
1. Biddinger et al. Familial aortic dilatations and dissections.
2. Katz et al. Gender differences in AAA prevalence.
3. Juvonen et al. Chlamydia in AAA tissue.
*May 97*
1. Satta et al. Procollagen peptide as AAA diagnostic.
2. Adolph et al. Cellular content and permeability of AAA thrombus.
*Jul 97*
1. Chen et al. Progress in AAA surgery.
*Aug 97*
1. White et al. Regression of AAA after endograft exclusion.
2. Grange et al. Pathogenesis of AAA (review).
*Sep 97*
1. Hirose et al. Molecular cloning of the mRNA of an additional
member of the family of aortic antigenic proteins.
2. Ozsvath et al. Expression of two novel recombinant proteins from
aortic adventitia.
*Oct 97*
1. Knoetgen et al. Detection of serum antibodies against an aortic
antigenic protein as a diagnostic.
2. Lederle et al. Risk factors for AAA in the screened VA population.
*Nov 97*
1. Tilson. Inflammatory and immune mechanisms in AAA.
*Dec 97*
1. Carmeliet et al. Urokinase generated plasmin activated MMP's in AAA.
*Jan 98*
1. Matsura et al. Learning curve & long-term outcomes for endovascular
grafts.
2. Weck et al. Murine gamma herpes virus 68 & large vessel arteritis.
*Feb 98*
1. Wain et al. Classification of endoleaks.
2. Kline et al. Laparoscopic-assisted AAA repair.
*Mar 98*
1. Adolph (repeated by accident)
2. Boyle et al. Doxycycline inhibits elastin degradation and MMP
activation in elastase-infusion AAA model.
*Apr 98*
1. May et al. Comparison of outcomes for endoluminal and conventional
AAA repair.
2. Lobato et al. Predictive factors for rupture of thoracoabdom aneurysm.
3. Hirose et al. Genetic risk factor for AAA (Japanese study)
*May 98*
1. Lipski et al. Long term fate of AAA sac after repair.
2. Vorp et al. Biomechanical stresses in AAA wall.
3. Lasseur et al. AAA in Behcet's disease.
*Jun 98*
1. McMillan et al. Increased plasma MMP-9 level in AAA.
2. Grange et al. MMP-2 expression by SMC's: Regulation by
macrophage/lymphocyte interactions.
3. Mirallas et al. PGE2 expression and rate of AAA expansion:
Regulation by COX2.
*Jul 98*
1. Tilson. T pallidum and AAA.
*Aug 98*
1. Torsello et al. Late rupture after endograft repair.
2. Scott et al. Rupture rates in small AAA's.
*Sep 98*
1. Hingorani et al. TNF-binding protein may reduce AAA formation in
elastase-infusion model.
2. Bobryshev et al. Dendritic cells in AAA immune response.
*Oct 98*
Medical centers participating in AneuryX and EVT endovascular trials.
*Nov 98*
1. Curci et al. Comparison with doxycycline with other agents for AAA
prevention.
2. Hamano et al. Type III collagen in aneurysm and dissection.
*Dec 98*
1. Curci et al. Expression & localization of MMP-12 in AAA
2. Allaire et al. Local overexpression of TIMP-1 prevents AAA in model.
*Jan 99*
1. McMillan et al. Increased plasma MMP-9 in AAA.
2. Bigatel et al. MMP inhibitor BB44 limits AAA expansion in model.
*Feb 99*
1. Thompson. History of aneurysm surgery.
2. Lawrence. Relationship of AAA to arteriomegaly.
3. Aneurysms in Behcet's disease.
*Mar 99*
1. Swartbol et al. IL-6 release during endovascular repair.
2. Melrose et al. Role of proteoglycans in AAA disease.
3. Jacobowitz et al. Explantation of EVT grafts.
4. Zarins et al. The AneuryX stent Trial
*Apr 99*
1. Coady et al. Familial thoracic aortic aneurysms.
*May 99*
1. Henretta et al. Endovascular repair under local anesthesia.
2. Jean-Claude et al. Pararenal aortic aneurysms.
3. Miralles et al. Indomethicin inhibits experimental AAA expansion.
*Jun 99*
1. Rutherford. Dissemination of information about endovascular repair.
2. Finlayson et al. Endovascular repair and threshold for surgery.
*Jul 99*
1. Gross et al. Relationship between NIH funding and burden of disease.
2. Chew et al. Regional distribution of an Aorta-Specific Antigenic Protein
(ASAP)
*Aug 99*
1. Loftus et al. True vein graft aneurysms.
2. Moore et al. MMP inhibitor suppresses experimental AAAs.
3. Quinones-Baldrich et al. Comparison of endovasc vs transperit vs retroperit
approaches.
*Sep 99*
1. Wilmink et al. Influence of screening on rate of ruptured AAAs.
2. Mid-term results of French Vanguard trial.
*Oct 99*
1. Bobryshev et al. Vascular Associated Lymphoid Tissue (VALT) in AAA
2. Carrell et al. Fibrinolytic and MMP activity in AAA thrombus.
3. Ichebuchi et al. MMP-9 production by SMC's from AAA wall.
4. Oppat et al. Transgenic mouse overexpresses MMP-9.
5. Schutzer et al. Localization of fibrillin in aortic adventitia & Marfan Sd.
*Nov 99*
1. Dobrin. Animal models of AAA.
2. Hirose et al. Negative genetic risk factor for AAA in Japan.
3. Lawrence et al. Epidemiology of surgery for AAA in USA.
*Dec 99*
1. Shi et al. Cystatin-C (a cystein proteinase) in AAA.
2. Kamijima et al. Expression of a non-muscle myosin isoform in AAA.
3. Mao et al. MMP-13 in AAA.
4. Curci et al. MMP-12 in AAA.
*Jan 00*
1. Kuiveinemi et al. Fibulin-2 as a candidate gene for AAA.
2. Wang et al. Non-coding transitions of TIMP genes in AAA.
3. Yoon et al. Transcriptionally more active 5A MMP3 allele in AAA.
4. Lindholt et al. Ig-A antibodies against Chlamydia P in AAA.
*Feb 00*
1. Reilly et al. Prostaglandin E-2 and IL-6 in AAA.
*Mar 00*
1. Rossack et al. Polymorphism in promotor region of PAI gene in AAA.
2. Rowe et al. Apoptosis in AAA SMC's.
3. Curci et al. Preoperative treatment of AAA with doxycycline decreases
MMP activity in tissue.
4. Raghavan et al. Wall stress distribution in 3-D for human AAA.
*Apr 00*
1. Dudley et al. Selective referral to high volume hospitals for AAA.
2. Schimmerhorn et al. Cost-benefit analysis of operation for small AAAs.
*May 00*
1. Santilli et al. Expansion rates for iliac artery aneurysms.
2. Ballota et al. Elongation of carotid artery and AAA
*Jun 00*
1. Lee et al. Erectile dysfunction after open AAA repair.
2. Chuter et al. Endovascular repair in high risk patients.
3. Politz et al. Late rupture after AneuryX repair.
4. Zarins et al. Ditto.